Manifestaciones pulmonares de las enfermedades del colágeno

Carrera, Luis Gómez; Hernán, Gema Bonilla

doi:10.1016/j.arbres.2012.11.005

Cited by 18 publications

(3 citation statements)

References 116 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 17 ] Insults to the lungs, including infectious and noninfectious causes, are often associated with an inflammatory process that eventually leads to airway destruction and, consequently, dilation of the bronchial tree. [ 16 19 20 21 22 23 ]…”

Section: Pathogenesismentioning

confidence: 99%

See 1 more Smart Citation

The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis

et al. 2017

View full text Add to dashboard Cite

This is the first guideline developed by the Saudi Thoracic Society for the diagnosis and management of noncystic fibrosis bronchiectasis. Local experts including pulmonologists, infectious disease specialists, thoracic surgeons, respiratory therapists, and others from adult and pediatric departments provided the best practice evidence recommendations based on the available international and local literature. The main objective of this guideline is to utilize the current published evidence to develop recommendations about management of bronchiectasis suitable to our local health-care system and available resources. We aim to provide clinicians with tools to standardize the diagnosis and management of bronchiectasis. This guideline targets primary care physicians, family medicine practitioners, practicing internists and respiratory physicians, and all other health-care providers involved in the care of the patients with bronchiectasis.

show abstract

Section: Pathogenesismentioning

confidence: 99%

“…These changes in pulmonary structure build a suitable environment for bacterial colonization and subsequent airway infections. [ 19 20 21 ] The repeated cycles of infection lead to further airway damage and the vicious cycle continues. Bronchiectasis is characterized by irreversibly dilated and abnormally thickened bronchial walls.…”

Section: Pathogenesismentioning

confidence: 99%

The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Starting from the first culprit step of the process-persistent or recurrent infection-we can identify two main etiological groups: (1) childhood infections, including persistent bacterial bronchitis (PBB) [11], pneumonia, measles, whooping cough and tuberculosis; and (2) adult infections, including non-tuberculous mycobacteria (NTM) infections [12]. Instead, progressive inflammation is the main pathophysiological determinant in other two etiological groups of NCFB: (1) toxic damage to airways, as in case of inhalation, aspiration secondary to neuromuscular diseases and gastro-oesophageal reflux disease (GERD), and (2) systemic inflammatory diseases, including inflammatory bowel disease [13], connective tissue diseases [14] and yellow nail syndrome [15]. In contrast, defects in the immune system are responsible of another etiological group of NCFB including primary and secondary immune deficiencies.…”

Section: Introductionmentioning

confidence: 99%

Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review

et al. 2021

View full text Add to dashboard Cite

Non-cystic fibrosis bronchiectasis is a chronic disorder in which immune system dysregulation and impaired airway clearance cause mucus accumulation and consequent increased susceptibility to lung infections. The presence of pathogens in the lower respiratory tract causes a vicious circle resulting in impaired mucociliary function, bronchial inflammation, and progressive lung injury. In current guidelines, antibiotic therapy has a key role in bronchiectasis management to treat acute exacerbations and chronic infection and to eradicate bacterial colonization. Contrastingly, antimicrobial resistance, with the risk of multidrug-resistant pathogen development, causes nowadays great concern. The aim of this literature review was to assess the role of antibiotic therapy in bronchiectasis patient management and possible concerns regarding antimicrobial resistance based on current evidence. The authors of this review stress the need to expand research regarding bronchiectasis with the aim to assess measures to reduce the rate of antimicrobial resistance worldwide.

show abstract

The Skin and Disorders of the Respiratory System

Molin

Ruzicka

2016

Rook's Textbook of Dermatology, Ninth Edition

View full text Add to dashboard Cite

There are many disorders that affect both the skin and the respiratory system, ranging from common infections and allergies to complex multisystem diseases. This chapter examines the relationship between the two organ systems and discusses selected disorders from amongst the diverse groups of diseases that may affect both. After a brief discussion of allergic disorders affecting the upper respiratory tract, the chapter focuses on pulmonary involvement in autoimmune disorders, vasculitides, infections and hereditary syndromes.

show abstract

Manifestaciones pulmonares de las enfermedades del colágeno

Cited by 18 publications

References 116 publications

The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis

The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis

Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review

The Skin and Disorders of the Respiratory System

Contact Info

Product

Resources

About